6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
1h ago	Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026
11h ago	Pony.ai Announces New Generation Autonomous Driving Compute Platform Built on NVIDIA DRIVE Hyperion
19h ago	IFS announces filing of 2025 Annual Report on Form 20-F
19h ago	Related Digital Announces Financing for $16 Billion Oracle Data Center Project in Saline Township, Michigan
19h ago	Questerre Energy Corporation Issues Clarification to Press Release from April 24, 2026

About

Medicinova Inc (NASDAQ:MNOV) — investor relations, events, news, and company updates on 6ix.

Latest News

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients

2026 New Year’s Greetings from the CEO

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

Message from the CEO to MediciNova Shareholders

Financials

Revenue

$409.66 K

Market Cap

$69.4 M

EPS

-0.24

Community Chat

Ask AI